What's breaking now, across thousands of outlets.
(MedPage Today) -- We've nominated medicine's biggest culture makers and moments of 2026. It's your turn to vote.
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
The results of a study found that women with higher blood levels of two common PFAS were more likely to develop estrogen receptor-negative breast cancer, saying their results have important public…
Health Canada has authorized Moderna's mRNA vaccine for influenza, as well as its combination mRNA vaccine for flu and COVID-19.
Readers respond to an article by John Harris on the rise in the number of people labelled autistic over the last 20 years John Harris’s article addresses all the main issues that are being debated…
The occurrence of cancer in nine recipients — two of which involved evidence that a viral delivery tool integrated into patient DNA — could raise new questions for the gene therapy field.
The FDA has granted accelerated approval to Johnson & Johnson’s cancer shot Rybrevant in head and neck cancer that’s come back after previous chemotherapy and immunotherapy.
(MedPage Today) -- The following is a transcript of the podcast episode: Rachael Robertson: Hey everybody! Welcome to MedPod Today, the podcast series where MedPage Today reporters share deeper…
